People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Adding an anti-obesity medication just one month after behavioral therapy begins-rather than waiting the currently recommended six months-can more than double weight loss for patients who struggle ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Of the estimated 15 million Americans now taking such medications for Type 2 diabetes and weight loss, only a relative few have experienced the issue, but for those who have, it’s life-altering.

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

There’s no question that the wildly popular injectable weight-loss drugs help people drop pounds, lower heart-disease risk, ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...